Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China

Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China
复制标题

中国回顾性队列抗结核治疗期间定期监测肝功能的效果

DOI:
10.1186/1471-2458-12-454
复制
发表时间:
2012-06
期刊:
影响因子:
4.5
通讯作者:
Cheng, Shiming
Cheng, Shiming
中科院分区:
医学2区
文献类型:
--
作者:
Zhan, Siyan;Xia, Yinyin;Lv, Xiaozhen;Zhang, Yuan;Tang, Shaowen;Yang, Zhirong;Tu, Dehua;Deng, Peiyuan;Cheng, Shiming

文献摘要

参考文献

相似文献

BackgroundData on effect of regular liver function monitoring during anti-TB treatment is limited in China. This study aimed to evaluate the effects of scheduled liver function monitoring on identification of asymptomatic liver damage and anti-TB treatment outcomes during anti-TB treatment.MethodsA retrospective analysis was performed based on a national-level cohort study. A total of 273 patients developing liver dysfunction were divided into two groups, 111 patients who were diagnosed through scheduled liver function test within two months after initiation of anti-TB treatment formed scheduled monitoring group, others who were diagnosed due to developing symptoms formed passive detection group (n = 162). The two groups were compared through clinical features, prognosis of liver dysfunction and impact on anti-TB treatment using propensity score weighting analysis.Results33.3% of 273 patients did not have any clinical symptoms, including 8 with severe hepatotoxicity. 1.8% in scheduled monitoring group and 11.1% in passive detection group required hospitalization (P = 0.004). Regarding the prognosis of liver dysfunction, most patients recovered, no death happened in scheduled monitoring group while 3 died in passive detection group. In terms of impact on anti-TB treatment, 35.1% in scheduled monitoring group and 56.8% in passive detection group changed their anti-TB treatment (P = 0.001).ConclusionsScheduled monitoring is effective in identifying asymptomatic liver damage, reducing hospitalization rate and improving compliance of anti-TB treatment.
DOI: 10.1007/s00108-019-00685-z
发表时间: 2019-11-01
期刊: INTERNIST
影响因子: --
作者:
Lange, Christoph;Kalsdorf, Barbara;Heyckendorf, Jan
通讯作者: Heyckendorf, Jan
DOI: --
发表时间: 2006
期刊: --
影响因子: --
作者:
J. Saukkonen;D. Cohn;R. Jasmer;S. Schenker;J. Jereb;C. Nolan;C. Peloquin;F. Gordin;D. Nunes;D. Strader;J. Bernardo;R. Venkataramanan;T. Sterling
通讯作者: J. Saukkonen;D. Cohn;R. Jasmer;S. Schenker;J. Jereb;C. Nolan;C. Peloquin;F. Gordin;D. Nunes;D. Strader;J. Bernardo;R. Venkataramanan;T. Sterling
DOI: --
发表时间: 2001-05
期刊: The National medical journal of India
影响因子: --
作者:
M. Thakur
通讯作者: M. Thakur
DOI: 10.1038/nrdp.2016.76
发表时间: 2016-10-27
影响因子: 81.5
作者:
Pai, Madhukar;Behr, Marcel A.;Raviglione, Mario
通讯作者: Raviglione, Mario